Bioactive Lipid (BAL)-Based Therapeutic Approach to Cancer That Enhances Antitumor Action and Ameliorates Cytokine Release Syndrome of Immune Checkpoint Inhibitors
Crossref DOI link: https://doi.org/10.1007/978-1-0716-0741-1_6
Published Online: 2020-05-31
Published Print: 2020
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Das, Undurti N.
Text and Data Mining valid from 2020-01-01
Version of Record valid from 2020-01-01
Chapter History
First Online: 31 May 2020